Custom Pharma Services
Simon Collis is an accomplished executive with extensive experience in commercial and business development within the pharmaceutical and healthcare sectors. Currently serving as Chief Commercial Officer at Custom Pharma Services, Simon leads initiatives aimed at delivering sustainable results through transformational strategies. Previous roles include strategic consultancy at SC Healthcare Consulting, Director of Global Business Development at IMI Critical Engineering, and Director of Global Commercial and Business Development at Britannia Pharmaceuticals Ltd, where Simon managed extensive sales operations, global marketing, and various strategic partnerships. Simon's career spans key positions focused on mergers and acquisitions, international expansion, and marketing strategies across multiple therapeutic areas, demonstrating a robust track record of driving growth and enhancing operational effectiveness in diverse environments.
This person is not in any teams
Custom Pharma Services
1 followers
Custom Pharma Services is located in Brighton, UK since 1979 and is a full-service contract development and manufacturing organisation (CDMO) providing services tailored to your needs, no matter how niche or complex. Custom covers the full spectrum of activities from development through commercial manufacturing for both clinical and commercial use. Specialising in Oral Solid Dosage forms with the ability to handle highly potent drugs and poorly bioavailable compounds Custom really is your one stop resource. With direct access to highly skilled experts offering a partnership approach Custom Pharma Services truly has a molecule first mentality, managing all projects with the end in mind. Custom Can! • Custom Pharma is a CDMO offering clinical and commercial manufacturing of tablets, capsules, powders (oral-solid-dose) for human use. • Services comprise pre-formulation and formulation development, analytical development, stability testing, clinical trial material manufacturing • Commercial Production • Pre-clinical formulation development and solubilisation • Material characterisation • Drug in capsule approach to accelerate early clinical studies • Specialists in low dosage (sub-mg) formulations • Contained manufacturing for highly potent APIs • Orphan drug development • Formulation development of poorly soluble drugs, including spray drying capabilities